Strata Critical Medical
(NASDAQ) SRTA
Strata Critical Medical Financials at a Glance
Market Cap
$425.32M
Revenue (TTM)
$197.14M
Net Income (TTM)
$41.35M
EPS (TTM)
$-0.19
P/E Ratio
-26.09
Dividend
$0.00
Beta (Volatility)
1.53 (High)
Dividend
$0.00
Beta (Volatility)
1.53 (High)
Price
$4.95
Volume
445,782
Open
$4.88
Price
$4.95
Volume
445,782
Open
$4.88
Previous Close
$4.95
Daily Range
$4.88 - $5.00
52-Week Range
$2.57 - $6.02
Dividend
$0.00
Beta (Volatility)
1.53 (High)
Price
$4.95
Volume
445,782
Open
$4.88
Previous Close
$4.95
Daily Range
$4.88 - $5.00
52-Week Range
$2.57 - $6.02
SRTA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Strata Critical Medical
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
601
CEO
William A. Heyburn; Melissa M. Tomkiel
Website
www.stratacritical.comHeadquarters
New York, NY 10001, US
SRTA Financials
Key Financial Metrics (TTM)
Gross Margin
21%
Operating Margin
-11%
Net Income Margin
21%
Return on Equity
-9%
Return on Capital
-7%
Return on Assets
13%
Earnings Yield
-3.83%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$425.32M
Shares Outstanding
86.45M
Volume
445.78K
Short Interest
0.00%
Avg. Volume
777.10K
Financials (TTM)
Gross Profit
$41.13M
Operating Income
$22.35M
EBITDA
$11.88M
Operating Cash Flow
$48.91M
Capital Expenditure
$9.60M
Free Cash Flow
$58.51M
Cash & ST Invst.
$61.23M
Total Debt
$3.31M
Strata Critical Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$22.74M
-58.2%
Gross Profit
$203.00K
-101.6%
Gross Margin
-0.89%
N/A
Market Cap
$425.32M
N/A
Market Cap/Employee
$1.37M
N/A
Employees
310
N/A
Net Income
$8.83M
+9.8%
EBITDA
$169.00K
+97.5%
Quarterly Fundamentals
Net Cash
$57.92M
-50.8%
Accounts Receivable
$39.96M
+85.1%
Inventory
$0.00
N/A
Long Term Debt
$2.65M
-55.9%
Short Term Debt
$652.00K
-80.3%
Return on Assets
12.70%
N/A
Return on Invested Capital
-7.31%
N/A
Free Cash Flow
$10.15M
-101.9%
Operating Cash Flow
$8.31M
-64000.0%